Ochronotic heart disease leading to severe aortic valve and coronary artery stenosis.
Ana K VelezNatalie A GaughanRosmi P ThomasStefano SchenaPublished in: Journal of cardiac surgery (2021)
Cardiac ochronosis is a rare disease, estimated to affect 1 in 250,000 persons. While there is extensive evidence of the musculoskeletal alterations of the disease, cardiac involvement has not been widely studied and most information we currently have derives from case reports and case series. We report the case of a 64-year old patient with a known history of alkaptonuria who presented with dyspnea and weight loss. On evaluation, he was found to have severe aortic stenosis, coronary artery disease, and interventricular septal hypertrophy. Surgery revealed extensive ochronotic pigment deposition affecting the cardiac septum, both internal thoracic arteries, the native coronary arteries, and the aortic valve. Ochronotic heart disease is an often disregarded presentation of alkaptonuria. More information is needed on the course of the disease, as well as long-term outcomes after valve replacement surgery and/or coronary artery bypass grafting in patients with alkaptonuria.
Keyphrases
- aortic valve
- aortic stenosis
- coronary artery disease
- transcatheter aortic valve replacement
- aortic valve replacement
- coronary artery bypass grafting
- transcatheter aortic valve implantation
- left ventricular
- coronary artery
- ejection fraction
- weight loss
- percutaneous coronary intervention
- coronary artery bypass
- minimally invasive
- case report
- pulmonary hypertension
- bariatric surgery
- spinal cord injury
- spinal cord
- early onset
- cardiovascular events
- heart failure
- type diabetes
- healthcare
- single cell
- body mass index
- palliative care
- cardiac resynchronization therapy